ADIPOQ and diabetes mellitus: In addition to the studies linking plasma adiponectin levels to various human diseases, human genetic studies provide evidence of an association between lower adiponectin levels and obesity, DM, dyslipidemia, hypertension, MetS, insulin resistance, and coronary artery disease (CAD) [15, 18].